Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             567 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 70. Abnormal cortico-thalamic-cerebellar circuitry in schizophrenia Eliaz, Y.
 2000
 47 8S1 p. S21-
1 p.
 artikel
2 153. Abnormalities in thalamus and prefrontal cortex during episodic object recognition in schizophrenia Heckers, S.
 2000
 47 8S1 p. S46-
1 p.
 artikel
3 194. Abnormal regulation of expressed genes in human brain diseases revealed using cDNA microarrays Pevsner, J.
 2000
 47 8S1 p. S59-
1 p.
 artikel
4 81. A cognitive, perceptual, and motor study of hemispheric asymmetry in the major psychoses Lohr, J.B.
 2000
 47 8S1 p. S25-
1 p.
 artikel
5 420. A comparison of neuropsychological profiles in patients with schizophrenia and bipolar psychoses Seidman, L.J.
 2000
 47 8S1 p. S129-
1 p.
 artikel
6 443. A controlled family study of early-onset obsessive-compulsive disorder Hanna, G.L.
 2000
 47 8S1 p. S135-S136
2 p.
 artikel
7 300. Activated lymphocytes in manic-depressive patients Issidorides, M.R.
 2000
 47 8S1 p. S91-
1 p.
 artikel
8 324. Activating brain regions involved in social attachment Lorberbaum, J.P.
 2000
 47 8S1 p. S97-S98
2 p.
 artikel
9 545. A double-blind, placebo-controlled study of naltrexone in the treatment of pathological gambling disorder Kim, S.-W.
 2000
 47 8S1 p. S166-
1 p.
 artikel
10 176. Advancing paternal age, new mutations and schizophrenia risk Malaspina, D.
 2000
 47 8S1 p. S53-
1 p.
 artikel
11 309. Age and parasympatholytic property of tricyclic antidepressants Kriechbaum, N.
 2000
 47 8S1 p. S93-S94
2 p.
 artikel
12 72. A genetic variant of CCK promoter region may link to negative symptom of schizophrenia Wang, Z.
 2000
 47 8S1 p. S22-
1 p.
 artikel
13 228. A genome scan using a pharmacogenetic approach indicates a susceptibility locus for BD on 15q14 Turecki, G.
 2000
 47 8S1 p. S69-S70
2 p.
 artikel
14 173. Age of onset of psychotic symptoms predicts information processing deficits in schizophrenia Kumari, V.
 2000
 47 8S1 p. S52-
1 p.
 artikel
15 167. Age of onset predicts grey matter loss in males with first episode schizophrenia Fannon, D.
 2000
 47 8S1 p. S50-
1 p.
 artikel
16 495. Aggression, anxiety, and salivary cortisol in child psychiatry inpatients McBurnett, K.
 2000
 47 8S1 p. S150-S151
2 p.
 artikel
17 260. A 1H-MRSI hippocampal study in bipolar patients with a history of alcohol abuse Frye, M.A.
 2000
 47 8S1 p. S79-
1 p.
 artikel
18 251. A likely error in the serotonin hypothesis Szekely, T.
 2000
 47 8S1 p. S76-
1 p.
 artikel
19 422. A longitudinal investigation of neuropsychological functioning and its relationship with symptomatology in first-episode psychosis Sharma, T.
 2000
 47 8S1 p. S129-
1 p.
 artikel
20 494. A longitudinal MRI study of children and adolescents with atypical psychotic disorders Nicolson, R.
 2000
 47 8S1 p. S150-
1 p.
 artikel
21 90. A longitudinal study of hippocampal volumes in schizophrenia Wood, S.J.
 2000
 47 8S1 p. S27-
1 p.
 artikel
22 392. Altered cortical development leads to dysfunctional limbic corticostriatal and dopaminergic circuits in the adult Moore, H.
 2000
 47 8S1 p. S119-
1 p.
 artikel
23 51. Altered GABA transporter-1 mRNA expression in prefrontal cortical neurons in schizophrenia Volk, D.W.
 2000
 47 8S1 p. S16-
1 p.
 artikel
24 148. Altered gene expression of dopaminergic markers in the midbrain of schizophrenic patients Keczkemethy, C.
 2000
 47 8S1 p. S45-
1 p.
 artikel
25 215. Altered hormonal response to a social stressor in major depression Young, E.A.
 2000
 47 8S1 p. S65-S66
2 p.
 artikel
26 89. Altered platelet mitochondrial complex I activity in schizophrenia Ben-Shachar, D.
 2000
 47 8S1 p. S27-
1 p.
 artikel
27 407. Altered prefrontal-thalamic neuronal integrity in bipolar I disorder Deicken, R.F.
 2000
 47 8S1 p. S124-S125
2 p.
 artikel
28 357. Altered relationships in RCMRGLU associativity in bipolar and unipolar illness Benson, B.E.
 2000
 47 8S1 p. S108-
1 p.
 artikel
29 397. A magnetic resonance imaging study of twins discordant for schizophrenia Cannon, T.D.
 2000
 47 8S1 p. S121-
1 p.
 artikel
30 382. A molecular pharmacological approach to the pathophysiology of schizophrenia Nishikawa, T.
 2000
 47 8S1 p. S116-S117
2 p.
 artikel
31 526. Amygdalar blood flow responses to facially expressed sadness Drevets, W.C.
 2000
 47 8S1 p. S160-
1 p.
 artikel
32 432. An association of a 5-HT5A receptor polymorphism, PRO15SER, to Japanese schizophrenia Iwata, N.
 2000
 47 8S1 p. S132-
1 p.
 artikel
33 342. Anatomical MRI study of basal ganglia in bipolar disorder patients Brambilla, P.
 2000
 47 8S1 p. S103-
1 p.
 artikel
34 165. An fMRI study of cognitive activation deficits in symptom-matched first episode and chronic schizophrenia patients O’Ceallaigh, S.
 2000
 47 8S1 p. S50-
1 p.
 artikel
35 493. An open trial of Wellbutrin SR in adolescents with depression Glod, C.A.
 2000
 47 8S1 p. S150-
1 p.
 artikel
36 487. Anterior cingulate n-acetylaspartate in childhood PTSD De Bellis, M.D.
 2000
 47 8S1 p. S148-
1 p.
 artikel
37 272. Antidepressant response and regional cerebral blood flow Little, J.T.
 2000
 47 8S1 p. S82-S83
2 p.
 artikel
38 528. Antiemetics mitigate nausea and vomiting in Alzheimer’s patients receiving rivastigmine Cutler, N.R.
 2000
 47 8S1 p. S161-
1 p.
 artikel
39 156. Antipsychotic regulation of signal transduction pathways Smith, R.E.
 2000
 47 8S1 p. S47-
1 p.
 artikel
40 6. An update on new somatic treatments for depression—ECT, TMS, VNS, DBS George, M.S
 2000
 47 8S1 p. S2-
1 p.
 artikel
41 399. A PET study of brain activation in response to auditory hallucinations and external speech in schizophrenic patients Copolov, D.L.
 2000
 47 8S1 p. S122-
1 p.
 artikel
42 317. A PET study of brain 5-HT2 receptors and their correlation with platelet 5-HT2 receptors Yatham, L.N.
 2000
 47 8S1 p. S95-S96
2 p.
 artikel
43 75. A pilot test of intensive computer-based cognitive training in schizophrenia Vinogradov, S.
 2000
 47 8S1 p. S23-
1 p.
 artikel
44 46. APOE E4 may modulate white matter microstructure in the elderly Crandall, D.T.
 2000
 47 8S1 p. S14-
1 p.
 artikel
45 147. A preliminary functional magnetic resonance study of high risk offspring of schizophrenic parents at 3.0 Tesla Spencer, S.
 2000
 47 8S1 p. S44-
1 p.
 artikel
46 521. A randomized, controlled trial of risperidone for psychotic features in PTSD Hamner, M.B.
 2000
 47 8S1 p. S158-S159
2 p.
 artikel
47 53. Are animal studies of antipsychotics appropriately dosed? Lessons from bedside to bench Kapur, S.
 2000
 47 8S1 p. S16-
1 p.
 artikel
48 219. A second look at comorbidity in victims of trauma: the PTSD—major depression connection Breslau, N.
 2000
 47 8S1 p. S66-S67
2 p.
 artikel
49 98. A self-report questionnaire to screen for prodromal schizophrenia Lencz, T.
 2000
 47 8S1 p. S30-
1 p.
 artikel
50 320. A SPECT study of gender and striatal dopamine Li, D.M.
 2000
 47 8S1 p. S96-
1 p.
 artikel
51 139. Assessing prepulse inhibition and P50 suppression in a single test session Light, G.A.
 2000
 47 8S1 p. S42-
1 p.
 artikel
52 367. Assessing the age-dependent profile of healthy normal controls using in vivo 31P MRS Stanley, J.A.
 2000
 47 8S1 p. S111-
1 p.
 artikel
53 492. Assessment of delayed response in pediatric OCD patients Shrikhande, A.
 2000
 47 8S1 p. S150-
1 p.
 artikel
54 568. Assessment of functioning in schizophrenia patients: findings from a new performance-based measure Patterson, T.L.
 2000
 47 8S1 p. S173-
1 p.
 artikel
55 87. Attention and medication in schizophrenia—an ERP study Brockhaus, A.
 2000
 47 8S1 p. S26-S27
2 p.
 artikel
56 164. Attenuated frontal activation during mental rotation in schizophrenia Swain, S.
 2000
 47 8S1 p. S49-S50
2 p.
 artikel
57 330. Atypical antipsychotic effects on fMRI in drug-naive schizophrenia Lencz, T.
 2000
 47 8S1 p. S99-
1 p.
 artikel
58 161. A voxel-by-voxel analysis of [18F] setoperone PET serotonin 2A receptor data in schizophrenia Verhoeff, N.P.L.G.
 2000
 47 8S1 p. S48-S49
2 p.
 artikel
59 96. Awareness of memory dysfunction in first-episode schizophrenia Goldman, R.S.
 2000
 47 8S1 p. S29-
1 p.
 artikel
60 4. A 20-year longitudinal study of risk factors for alcoholism Schuckit, M.A.
 2000
 47 8S1 p. S1-S2
2 p.
 artikel
61 412. Baseline hypofrontality and divalproex response in bipolar disorders Ketter, T.A.
 2000
 47 8S1 p. S126-
1 p.
 artikel
62 73. BCL-2 protein reduced in schizophrenic temporal cortex Jarskog, L.F.
 2000
 47 8S1 p. S22-
1 p.
 artikel
63 391. Behavioral consequences of corticostriatal dysfunction produced by phencyclidine administration Jentsch, J.D.
 2000
 47 8S1 p. S119-
1 p.
 artikel
64 93. Behavioral profiles of adolescents putatively prodromal for schizophrenia Pappadopulos, E.
 2000
 47 8S1 p. S28-
1 p.
 artikel
65 523. Behavioral response to oxytocin challenge in adult autistic disorders Novotny, S.L.
 2000
 47 8S1 p. S159-
1 p.
 artikel
66 32. Behavior genetics of the serotonin transporter: searching for epistatic interactions Lesch, K.-P.
 2000
 47 8S1 p. S9-S10
2 p.
 artikel
67 202. Bereavement and depression: immune concomitant Keller, S.E.
 2000
 47 8S1 p. S62-
1 p.
 artikel
68 262. Biochemical alterations in monoamines induced by TMS in rats and SH-SY5Y cells Klein, E.
 2000
 47 8S1 p. S79-S80
2 p.
 artikel
69 200. Biopsychological profile of normal, bereaved and post-bereaved depressed elderly Khin, N.A.
 2000
 47 8S1 p. S61-
1 p.
 artikel
70 441. Bipolar disorder: dopamine genes association study Muglia, P.
 2000
 47 8S1 p. S135-
1 p.
 artikel
71 393. Birth complications and dopamine function in animal models: implications for schizophrenia Boksa, P.
 2000
 47 8S1 p. S120-
1 p.
 artikel
72 145. Blunted brain metabolic response to ketamine in mice lacking D1A dopamine receptors Miyamoto, S.
 2000
 47 8S1 p. S44-
1 p.
 artikel
73 255. Body composition and regional fat content in patients with major depression Negro Jr., P.J.
 2000
 47 8S1 p. S77-S78
2 p.
 artikel
74 259. Body mass and depressive and anxiety symptoms Chapman, D.P.
 2000
 47 8S1 p. S78-S79
2 p.
 artikel
75 314. Brain chemistry in pediatric depression Rosenberg, D.R.
 2000
 47 8S1 p. S95-
1 p.
 artikel
76 316. Brain 5-HT2 receptors in major depression: a PET study Yatham, L.N.
 2000
 47 8S1 p. S95-
1 p.
 artikel
77 331. Brain volume in autism Hardan, A.
 2000
 47 8S1 p. S99-S100
2 p.
 artikel
78 21. Bulimia nervosa: a disturbance of serotonin/orbital frontal cortex modulation? Kaye, W.H.
 2000
 47 8S1 p. S6-
1 p.
 artikel
79 466. Caffeine disrupts sleep in old rats when compared to young rats Salı́n-Pascual, R.J.
 2000
 47 8S1 p. S142-
1 p.
 artikel
80 195. Can differential display make a difference in biological psychiatry? Strakhova, M.I.
 2000
 47 8S1 p. S59-S60
2 p.
 artikel
81 323. Can interleaved TMS and fMRI demonstrate changes in an activated circuit? Lomarev, M.
 2000
 47 8S1 p. S97-
1 p.
 artikel
82 452. Caudate and ventricular volume in unmedicated schizotypal personality disorder Levitt, J.J.
 2000
 47 8S1 p. S138-
1 p.
 artikel
83 170. Caudate nucleus abnormalities in first episode psychosis Chitnis, X.A.
 2000
 47 8S1 p. S51-
1 p.
 artikel
84 384. cDNA arrays in neuroscience research: a practical approach Becker, K.G.
 2000
 47 8S1 p. S117-
1 p.
 artikel
85 123. Cerebellar gray matter volume deficits in schizophrenia and alcoholism Sullivan, E.V.
 2000
 47 8S1 p. S37-
1 p.
 artikel
86 250. Cerebral metabolite changes in women with PMDD Rasgon, N.L.
 2000
 47 8S1 p. S76-
1 p.
 artikel
87 269. Changes in anxiety after prefrontal rTMS in patients with GAD Lorberbaum, J.P.
 2000
 47 8S1 p. S81-S82
2 p.
 artikel
88 506. Changes of autonomic heart rate parameters during treatment with clozapine, olanzapine, and haloperidol Cohen, H.
 2000
 47 8S1 p. S154-
1 p.
 artikel
89 413. Characterization of four human neuronal voltage-gated calcium channel γ subunit genes Black III, J.L.
 2000
 47 8S1 p. S126-S127
2 p.
 artikel
90 230. Characterization of the dopamine D1 receptor transgenic mice Dracheva, S.
 2000
 47 8S1 p. S70-
1 p.
 artikel
91 477. Characterizing the diurnal rhythm of DHEA and effects of an oral dose of alprazolam Erosheva, E.A.
 2000
 47 8S1 p. S145-
1 p.
 artikel
92 296. Childhood cognitive functioning in adult patients with affective illness and their siblings Sanchez, L.E.
 2000
 47 8S1 p. S89-S90
2 p.
 artikel
93 498. Chronic haloperidol administration significantly increases striatal volumes in the RAT Andersson, C.
 2000
 47 8S1 p. S151-S152
2 p.
 artikel
94 355. Cingulate metabolism predicts treatment response: a replication Brannan, S.K.
 2000
 47 8S1 p. S107-
1 p.
 artikel
95 491. Citalopram treatment and breast-feeding Lepola, U.
 2000
 47 8S1 p. S149-
1 p.
 artikel
96 84. Clinical correlates of structural brain abnormalities in schizophrenia Chakos, M.H.
 2000
 47 8S1 p. S25-S26
2 p.
 artikel
97 204. Clinical implications of the inverted U-shaped curve relating D1 stimulation and behavior Goldman-Rakic, P.S.
 2000
 47 8S1 p. S62-
1 p.
 artikel
98 24. Clinical, neuropathological and neuroimaging correlates of frontotemporal dementia (FTD) Kumar, A.
 2000
 47 8S1 p. S7-
1 p.
 artikel
99 36. Clinical profile of substance P antagonists Kramer, M.S.
 2000
 47 8S1 p. S11-
1 p.
 artikel
100 414. Clozapine-induced upregulation of apolipoprotein D expression in mouse brain Thomas, E.A.
 2000
 47 8S1 p. S127-
1 p.
 artikel
101 92. Clozapine in therapy-resistant schizophrenia: experience from Pakistan Chaudhry, H.R.
 2000
 47 8S1 p. S28-
1 p.
 artikel
102 425. Cocaine effects on striatal dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) protein in humans Oakman, S.
 2000
 47 8S1 p. S130-
1 p.
 artikel
103 113. Cognitive deficits and the schizophrenia spectrum Mitropoulou, V.
 2000
 47 8S1 p. S34-
1 p.
 artikel
104 49. Cognitive deficits predict prefrontal volume decline in schizophrenia Mathalon, D.H.
 2000
 47 8S1 p. S15-
1 p.
 artikel
105 169. Cognitive impairment predicted by the degree of premorbid deterioration in first episode schizophrenia Fannon, D.
 2000
 47 8S1 p. S51-
1 p.
 artikel
106 100. Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia Breier, A.
 2000
 47 8S1 p. S30-S31
2 p.
 artikel
107 298. Comparison of risperidone and olanzapine in bipolar and schizoaffective disorders Masand, P.S.
 2000
 47 8S1 p. S90-
1 p.
 artikel
108 115. Confirmation of differing distribution of P50 ratios in schizophrenic patients vs controls Adler, L.E.
 2000
 47 8S1 p. S35-
1 p.
 artikel
109 375. Consciousness of extrapersonal space—a model system for understanding neurocognitive networks and their hemispheric asymmetry Mesulam, Marsel
 2000
 47 8S1 p. S114-
1 p.
 artikel
110 332. Corpus callosum size in autism Hardan, A.
 2000
 47 8S1 p. S100-
1 p.
 artikel
111 64. Correlations between four components of sensory gating Boutros, N.N.
 2000
 47 8S1 p. S19-S20
2 p.
 artikel
112 135. Correlations between RBC fatty acids and 31P MRS brain measures in schizophrenia Yao, J.K.
 2000
 47 8S1 p. S41-
1 p.
 artikel
113 454. Cortical and depth data of P50 gating in humans; a report of two cases Boutros, N.N.
 2000
 47 8S1 p. S139-
1 p.
 artikel
114 350. Cortical and subcortical activation in response to emotional probes Liberzon, I.
 2000
 47 8S1 p. S106-
1 p.
 artikel
115 395. Cortical and subcortical volumes in patients with schizotypal personality disorder Siever, L.J.
 2000
 47 8S1 p. S120-S121
2 p.
 artikel
116 456. Cortical excitability in cocaine-dependent subjects; preliminary data Boutros, N.N.
 2000
 47 8S1 p. S139-
1 p.
 artikel
117 304. Cortical GABA reduced in unipolar but not bipolar depression Mason, G.F.
 2000
 47 8S1 p. S92-
1 p.
 artikel
118 288. Corticosteroid receptor regulation in the brains of suicide victims López, J.F.
 2000
 47 8S1 p. S87-
1 p.
 artikel
119 208. Corticotropin releasing factor, stress and allostasis Koob, G.F.
 2000
 47 8S1 p. S63-S64
2 p.
 artikel
120 60. Craving reduction and clozapine response in patients with comorbid substance abuse and schizophrenia Buckley, P.F.
 2000
 47 8S1 p. S18-S19
2 p.
 artikel
121 210. CRF1 receptor antagonists as novel putative antidepressants and anxiolytics Nemeroff, C.B.
 2000
 47 8S1 p. S64-
1 p.
 artikel
122 209. CRF-receptors as drug targets for treatment of anxiety and depression Holsboer, F.
 2000
 47 8S1 p. S64-
1 p.
 artikel
123 479. CSF 5-HIAA and aggression in primates: species and interindividual differences Westergaard, G.C.
 2000
 47 8S1 p. S146-
1 p.
 artikel
124 559. Current cogntive functioning versus premorbid status as predictors of levels of functioning Harvey, P.D.
 2000
 47 8S1 p. S170-
1 p.
 artikel
125 445. Cyclooxygenase and brain development: implications in Rett’s syndrome Stamu, C.
 2000
 47 8S1 p. S136-
1 p.
 artikel
126 63. Cytokine production in schizophrenic patients: differential effect of neuroleptic medications Sirota, P.
 2000
 47 8S1 p. S19-
1 p.
 artikel
127 144. Cytokine regulation of embryonic cortical neuron survival: implications for schizophrenia Marx, C.E.
 2000
 47 8S1 p. S43-
1 p.
 artikel
128 294. Cytokine secretion and treatment response in major depression Vedder, H.
 2000
 47 8S1 p. S89-
1 p.
 artikel
129 409. Decision-making in schizophrenia: dysregulation of the neural substrate Paulus, M.P.
 2000
 47 8S1 p. S125-
1 p.
 artikel
130 366. Decreased caudate dopamine function in depressed patients with retarded depression Paillère-Martinot, M.-L.
 2000
 47 8S1 p. S110-S111
2 p.
 artikel
131 158. Decreased vesicular monoamine transporter density in schizophrenic prefrontal cortex Meador-Woodruff, J.H.
 2000
 47 8S1 p. S48-
1 p.
 artikel
132 374. Deep brain stimulation: a new treatment for Parkinson’s disease with mood altering potential Kumar, R.
 2000
 47 8S1 p. S113-
1 p.
 artikel
133 313. Depersonalization disorder: neural correlates of thinking without feeling Phillips, M.L.
 2000
 47 8S1 p. S94-S95
2 p.
 artikel
134 307. Depressed outpatients have elevated temperatures Rausch, J.L.
 2000
 47 8S1 p. S93-
1 p.
 artikel
135 91. Depression and higher IQ associated with premorbid TBI in schizophrenia Corcoran, C.M.
 2000
 47 8S1 p. S28-
1 p.
 artikel
136 271. Depression in asthma patients: preliminary findings Brown, E.S.
 2000
 47 8S1 p. S82-
1 p.
 artikel
137 207. Development of non-peptide antagonist ligands acting for CRF1 receptors Grigoriadis, D.E.
 2000
 47 8S1 p. S63-
1 p.
 artikel
138 328. Differences in white matter connectivity in men and women with and without schizophrenia Amodei, L.
 2000
 47 8S1 p. S99-
1 p.
 artikel
139 335. Differential amygdalar response to the arousal but not to the emotional content of visual stimuli Pendergrass, J.C.
 2000
 47 8S1 p. S101-
1 p.
 artikel
140 383. Differential cloning and DNA microarrays in depression research Yamada, M.
 2000
 47 8S1 p. S117-
1 p.
 artikel
141 451. Differential effects of antidepressants on the viability of clonal hippocampal cells Post, A.
 2000
 47 8S1 p. S138-
1 p.
 artikel
142 154. Differential effects of antipsychotics on neurotransmitter receptor expression Healy, D.J.
 2000
 47 8S1 p. S46-S47
2 p.
 artikel
143 437. Differential expression of newly identified gene with RING-H2 finger motif after chronic antidepressant treatment in rat brain Yamada, M.
 2000
 47 8S1 p. S134-
1 p.
 artikel
144 29. Differential gene expression in human postmortem Rett syndrome brain revealed by cDNA microarray Colantuoni, C.
 2000
 47 8S1 p. S8-S9
2 p.
 artikel
145 322. Diffusion tensor imaging in schizophrenia and schizophrenia spectrum disorders Shihabuddin, L.
 2000
 47 8S1 p. S97-
1 p.
 artikel
146 235. Disease progression in a model for the course of recurrent mood disorders Krieg, J.-C.
 2000
 47 8S1 p. S71-S72
2 p.
 artikel
147 513. Disordered gambling and excessive tobacco use: addiction spectrum behaviors? Potenza, M.N.
 2000
 47 8S1 p. S156-
1 p.
 artikel
148 205. Distinct contribution of glutamate and dopamine receptors to the temporal range of rodent working memory using a task with elements of human working memory Moghaddam, B.
 2000
 47 8S1 p. S62-S63
2 p.
 artikel
149 85. Disturbances of auditory information processing in schizophrenia reflected by MMN Brockhaus, A.
 2000
 47 8S1 p. S26-
1 p.
 artikel
150 80. Does response mode affect detection of P300 asymmetry in schizophrenia? Salisbury, D.F.
 2000
 47 8S1 p. S24-
1 p.
 artikel
151 270. Donepezil augmentation for cognitive impairment in euthymic bipolar patients Goldman, J.
 2000
 47 8S1 p. S82-
1 p.
 artikel
152 57. Donepezil augmentation of antipsychotics in schizophrenia: cognitive and fMRI effects Risch, S.C.
 2000
 47 8S1 p. S17-S18
2 p.
 artikel
153 33. Dopamine D4 receptor, serotonin transporter genotypes and temperament in early childhood Ebstein, R.P.
 2000
 47 8S1 p. S10-
1 p.
 artikel
154 240. Dopamine function in men with bipolar depression Duval, F.
 2000
 47 8S1 p. S73-
1 p.
 artikel
155 243. Dopaminergic function and HPA axis activity in psychotic depression Duval, F.
 2000
 47 8S1 p. S74-
1 p.
 artikel
156 480. Dopaminergic innervation of the primate mediodorsal thalamic nucleus Melchitzky, D.S.
 2000
 47 8S1 p. S146-
1 p.
 artikel
157 370. Dopamine transporter (DAT 1) genotypes and [123I]-β-CIT SPECT imaging of DAT in Tourette Disorder (TD) Stamenkovic, M.
 2000
 47 8S1 p. S112-
1 p.
 artikel
158 206. Dorsal and ventral PFC responses to working memory differ in schizophrenia Callicott, J.H.
 2000
 47 8S1 p. S63-
1 p.
 artikel
159 344. Dorsolateral prefrontal cortex abnormalities in bipolar disorder—possible effects of lithium treatment? Figueroa, R.
 2000
 47 8S1 p. S103-S104
2 p.
 artikel
160 373. Double-blind controlled trial of embryonic dopaminergic tissue transplants in advanced Parkinson’s disease Fahn, S.
 2000
 47 8S1 p. S113-
1 p.
 artikel
161 464. Down-regulation of tyrosine hydroxylase in rat locus coeruleus by reboxetine Ordway, G.A.
 2000
 47 8S1 p. S141-
1 p.
 artikel
162 188. Driving: quantification and application in neuropsychiatry Pearlson, G.D.
 2000
 47 8S1 p. S57-
1 p.
 artikel
163 278. DST results and completed suicide in major depressive disorder Coryell, W.H.
 2000
 47 8S1 p. S84-
1 p.
 artikel
164 555. Early ERPS and their contribution to diagnosis in schizophrenia Ruhrmann, S.
 2000
 47 8S1 p. S169-
1 p.
 artikel
165 35. Early rearing & genotypic influences on CNS serotonin & behavior in nonhuman primates Higley, J.D.
 2000
 47 8S1 p. S10-S11
2 p.
 artikel
166 446. Effect of aging on 5-lipoxygenase (5-LOX) mRNA and protein in the rat brain Qu, T.
 2000
 47 8S1 p. S136-
1 p.
 artikel
167 481. Effect of maternal separation on behavioural analogues of depression in C57BL/6J mice Ramakrishnan, K.
 2000
 47 8S1 p. S146-S147
2 p.
 artikel
168 232. Effects of acute and chronic social stress on levels of CSF corticotropin-releasing hormone Gerald, M.S.
 2000
 47 8S1 p. S71-
1 p.
 artikel
169 337. Effects of a simulated scanner environment on the auditory evoked P50 potential Erwin, R.J.
 2000
 47 8S1 p. S101-
1 p.
 artikel
170 122. Effects of caffeine on sensorimotor gating of the startle reflex in normal control subjects Swerdlow, N.R.
 2000
 47 8S1 p. S37-
1 p.
 artikel
171 475. Effects of chronic stress on the HPA of male and female rats Zimmer, C.A.
 2000
 47 8S1 p. S145-
1 p.
 artikel
172 289. Effects of cortisol on sleep EEG and growth hormone secretion in major depression depending on HPA-function? Schmid, D.A.
 2000
 47 8S1 p. S87-S88
2 p.
 artikel
173 14. Effects of gonadal steroids on the HPA axis response to stress Roca, C.A.
 2000
 47 8S1 p. S5-
1 p.
 artikel
174 285. Effects of hydrocortisone on β-adrenoceptor coupling to GS protein in depression before and after treatment Gurguis, G.
 2000
 47 8S1 p. S86-
1 p.
 artikel
175 155. Effects of lesion size, age and strain on behavioral responsiveness to hippocampal damage in mice Williams, K.A.
 2000
 47 8S1 p. S47-
1 p.
 artikel
176 536. Effects of light therapy in dementia Neumeister, A.
 2000
 47 8S1 p. S163-
1 p.
 artikel
177 86. Effects of medication on N100 topography in schizophrenia Ruhrman, S.
 2000
 47 8S1 p. S26-
1 p.
 artikel
178 238. Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder Yeragani, V.K.
 2000
 47 8S1 p. S72-S73
2 p.
 artikel
179 315. Effects of rapid tryptophan depletion on brain 5-HT2 receptors: a PET study Yatham, L.N.
 2000
 47 8S1 p. S95-
1 p.
 artikel
180 265. Effects of reboxetin on the sleep EEG of patients with depression Kuenzel, H.
 2000
 47 8S1 p. S80-S81
2 p.
 artikel
181 362. Effects of tryptophan depletion on SPECT measures of cerebral blood flow Konopka, L.M.
 2000
 47 8S1 p. S109-
1 p.
 artikel
182 522. Efficacy of mirtazapine in stimulant associated insomnia in patients with ADHD Adler, L.A.
 2000
 47 8S1 p. S159-
1 p.
 artikel
183 376. Eicosanoid pathways and psychiatric disorders Ho, L.
 2000
 47 8S1 p. S114-
1 p.
 artikel
184 372. Electroconvulsive therapy: dowager or neophyte? Sackeim, H.A.
 2000
 47 8S1 p. S113-
1 p.
 artikel
185 428. Electroencephalographic abnormalities in patients with clozapine Chung, S.J.
 2000
 47 8S1 p. S131-
1 p.
 artikel
186 553. Electrophysiologic predictors of response to antidepressant treatment Bruder, G.E.
 2000
 47 8S1 p. S168-S169
2 p.
 artikel
187 71. Elevated dopamine-induced Gs protein measures in patients with schizophrenia Avissar, S.
 2000
 47 8S1 p. S22-
1 p.
 artikel
188 233. Elevated thyroid hormone levels in brains of congenital learned helpless rats Nobrega, J.
 2000
 47 8S1 p. S71-
1 p.
 artikel
189 538. Elevation in CSF CRH and reduction in CSF MHPG during pregnancy Altemus, M.
 2000
 47 8S1 p. S164-
1 p.
 artikel
190 365. Emotion-inducing stimuli processing in alexithymia: an fMRI study Berthoz, S.
 2000
 47 8S1 p. S110-
1 p.
 artikel
191 55. ERP evidence of frontal/posterior disconnection in schizophrenia Potts, G.F.
 2000
 47 8S1 p. S17-
1 p.
 artikel
192 552. Ethanol induced suppressibility of cytokine production in patients with major depressive disorder (MDD) Lanquillon, S.
 2000
 47 8S1 p. S168-
1 p.
 artikel
193 329. Evaluation of citalopram as a pharmacologic intervention of the serotonin system Smith, G.S.
 2000
 47 8S1 p. S99-
1 p.
 artikel
194 258. Evidence for antidepressant effect of cigarette smoking in human brain Klimek, V.
 2000
 47 8S1 p. S78-
1 p.
 artikel
195 469. Evidence of increased neuronal dysfunction in Alzheimer’s disease with psychosis Sweet, R.A.
 2000
 47 8S1 p. S143-
1 p.
 artikel
196 166. Evidence of localized structural brain abnormality in first episode schizophrenia Fannon, D.
 2000
 47 8S1 p. S50-
1 p.
 artikel
197 424. Executive function deficits in adults with attention deficit hyperactivity disorder (ADHD) Vassileva, J.L.
 2000
 47 8S1 p. S130-
1 p.
 artikel
198 59. Expanding use of atypical antipsychotics Buckley, P.F.
 2000
 47 8S1 p. S18-
1 p.
 artikel
199 162. Exploring orbitofrontal dysfunction in schizophrenia: a neuropsychological assay Shurman, B.D.
 2000
 47 8S1 p. S49-
1 p.
 artikel
200 157. Expression of exon 22-containing NR1 NMDA receptor subunits in thalamus in schizophrenia Clinton, S.M.
 2000
 47 8S1 p. S47-
1 p.
 artikel
201 458. Extracellular levels of GABA and glutamate increase in response to direct electrical stimulation of the hippocampus in humans: an in vivo microdialysis study Abi-Saab, W.M.
 2000
 47 8S1 p. S140-
1 p.
 artikel
202 61. Extracranial size in patients with schizophrenia Buckley, P.F.
 2000
 47 8S1 p. S19-
1 p.
 artikel
203 137. Extraction of total RNA in human brain post-mortem tissue: effect of diagnosis on RNA yield Tomaskovic-Crook, E.
 2000
 47 8S1 p. S41-
1 p.
 artikel
204 134. Eye gaze direction discrimination in schizophrenia Niendam, T.
 2000
 47 8S1 p. S40-
1 p.
 artikel
205 222. Facilitation of prefrontal function in schizophrenia by increasing socioaffective input Park, S.
 2000
 47 8S1 p. S67-S68
2 p.
 artikel
206 41. Familial schizophrenia spectrum disorders in childhood-and adult-onset schizophrenia Nicolson, R.
 2000
 47 8S1 p. S12-S13
2 p.
 artikel
207 527. Family relationship characteristics in anorexia nervosa Casper, R.C.
 2000
 47 8S1 p. S160-S161
2 p.
 artikel
208 515. Feasibility and efficacy of left prefrontal rTMS as a maintenance antidepressant Nahas, Z.
 2000
 47 8S1 p. S156-S157
2 p.
 artikel
209 308. Fluoxetine treatment in patients with recurrent brief depression (RBD) Stamenkovic, M.
 2000
 47 8S1 p. S93-
1 p.
 artikel
210 336. fMRI activation patterns of attention and working memory in alcoholics Pfefferbaum, A.
 2000
 47 8S1 p. S101-
1 p.
 artikel
211 520. FMRI of neuronal activation with symptom provocation in unmedicated OCD patients Adler, C.M.
 2000
 47 8S1 p. S158-
1 p.
 artikel
212 333. fMRI using the auditory mismatch negativity task in schizophrenics Wible, C.G.
 2000
 47 8S1 p. S100-
1 p.
 artikel
213 Foreword Richelson, Elliott
 2000
 47 8S1 p. vi-
1 p.
 artikel
214 78. Fornix and mammillary body volumes in individuals with schizophrenia Cirillo, M.A.
 2000
 47 8S1 p. S24-
1 p.
 artikel
215 388. From candidate symptoms and endophenotypes to candidate genes Leboyer, M.
 2000
 47 8S1 p. S118-
1 p.
 artikel
216 111. Frontal cortex dysfunction and subcortical dopaminergic activity in schizophrenia spectrum Goodman, M.
 2000
 47 8S1 p. S34-
1 p.
 artikel
217 378. Frontal cortical function and drug abuse Lynch, M.R.
 2000
 47 8S1 p. S115-
1 p.
 artikel
218 380. Functional deficit in schizophrenia: course, correlates, and etiological factors Harvey, Philip D.
 2000
 47 8S1 p. S116-
1 p.
 artikel
219 385. Functional genomics and gene knockout strategy Sora, I.
 2000
 47 8S1 p. S117-
1 p.
 artikel
220 325. Functional MRI and formal thought disorder Rivkin, P.
 2000
 47 8S1 p. S98-
1 p.
 artikel
221 327. Functional MRI of implicit learning in Huntington’s disease Brashers-Krug, T.
 2000
 47 8S1 p. S98-
1 p.
 artikel
222 398. Functional MRI studies of auditory hallucinations McGuire, P.K.
 2000
 47 8S1 p. S122-
1 p.
 artikel
223 347. Functional MRI study of forebrain activation in OCD Ursu, S.
 2000
 47 8S1 p. S104-S105
2 p.
 artikel
224 433. Functional variants at CYP2A6: new genotyping methods, population genetics, and relevance to studies of tobacco dependence Zabetian, C.P.
 2000
 47 8S1 p. S132-S133
2 p.
 artikel
225 7. GABA/glutamate dysregulation in depression Murck, H.
 2000
 47 8S1 p. S2-S3
2 p.
 artikel
226 569. Gamma frequency auditory processing abnormalities in schizophrenia McCarley, R.W.
 2000
 47 8S1 p. S173-
1 p.
 artikel
227 45. Gender differences in aging effect on the 5-HTlA receptor with [11C-carbonyl]way100635 PET Meltzer, C.C.
 2000
 47 8S1 p. S14-
1 p.
 artikel
228 543. Gender differences in emotional recognition and hemispheric asymmetry Imig, J.C.
 2000
 47 8S1 p. S165-
1 p.
 artikel
229 326. Gender differences in hippocampal, amygdaloid and frontal volumes across the lifespan: a cross-sectional study Honeycutt, N.A.
 2000
 47 8S1 p. S98-
1 p.
 artikel
230 191. Gene expression arrays: their power and their limits Watson, S.J.
 2000
 47 8S1 p. S58-
1 p.
 artikel
231 429. Gene polymorphism of tryptophan hydroxylase in Korean alcoholics Chung, I.-W.
 2000
 47 8S1 p. S131-
1 p.
 artikel
232 193. Genes regulated by antidepressant treatments Thompson, R.C.
 2000
 47 8S1 p. S59-
1 p.
 artikel
233 180. Genetic dissection of neurodegenerative disease Hardy, J.
 2000
 47 8S1 p. S54-
1 p.
 artikel
234 402. Genetics and neurobiology of sensorimotor gating: the gain in brain comes mainly in the strain Swerdlow, N.R.
 2000
 47 8S1 p. S123-
1 p.
 artikel
235 30. Genetics of autism Buxbaum, J.D.
 2000
 47 8S1 p. S9-
1 p.
 artikel
236 386. Genetic variation in dopamine and serotonin function Goldman, D.
 2000
 47 8S1 p. S117-S118
2 p.
 artikel
237 499. Glial fibrillary tangles in patients with late onset schizophrenia Casanova, M.F.
 2000
 47 8S1 p. S152-
1 p.
 artikel
238 13. Gonadal steroids, brain, and behavior Schmidt, P.J.
 2000
 47 8S1 p. S5-
1 p.
 artikel
239 287. Histone H2B on lymphocyte membranes of patients with bipolar disorder Sourlingas, T.G.
 2000
 47 8S1 p. S87-
1 p.
 artikel
240 273. Hostility and associated cholesterol levels in panic disorder patients Bailey, D.
 2000
 47 8S1 p. S83-
1 p.
 artikel
241 508. How specific are deficits in generation of mismatch negativity to schizophrenia? Umbricht, D.
 2000
 47 8S1 p. S154-
1 p.
 artikel
242 218. HPA axis regulation in premenopausal women with PTSD Rasmusson, A.M.
 2000
 47 8S1 p. S66-
1 p.
 artikel
243 247. HPA axis response to graded exercise in atypical depression Negrão, A.B.
 2000
 47 8S1 p. S75-
1 p.
 artikel
244 539. HPA axis response to metyrapone is stable across menstrual cycle Altemus, M.
 2000
 47 8S1 p. S164-
1 p.
 artikel
245 58. 5-HT2A receptor blockade by quetiapine is related to its side effect profile Jones, H.M.
 2000
 47 8S1 p. S18-
1 p.
 artikel
246 286. 5-HT2A receptors in depression pre/post paroxetine Meyer, J.H.
 2000
 47 8S1 p. S87-
1 p.
 artikel
247 423. 5-HT2 receptor activation: a common denominator of the NMDA antagonist and 5-HT2A agonist models of psychosis? Vollenweider, F.X.
 2000
 47 8S1 p. S129-S130
2 p.
 artikel
248 361. 5-HTTLPR and central 5-HTT availability measured with [123I]-β-CIT SPECT Willeit, M.
 2000
 47 8S1 p. S109-
1 p.
 artikel
249 461. Hypothalamic-pituitary-adrenal axis activity and personality assessment Negro Jr, P.J.
 2000
 47 8S1 p. S140-S141
2 p.
 artikel
250 471. Hypothalamic-pituitary-adrenal axis activity in personality disordered subjects: associations with psychological trauma and comorbid PTSD Grossman, R.
 2000
 47 8S1 p. S143-S144
2 p.
 artikel
251 415. Identification of candidate genes in schizophrenia using animal models Wong, A.H.C.
 2000
 47 8S1 p. S127-
1 p.
 artikel
252 514. Identifying alcohol abuse: MDs and the cage Gold, M.S.
 2000
 47 8S1 p. S156-
1 p.
 artikel
253 23. Imaging the serotonin system in aging and late-life neuropsychiatric disorders Meltzer, C.C.
 2000
 47 8S1 p. S6-S7
2 p.
 artikel
254 517. Immunoreactivity of stress proteins in brainstem neurons of chronic alcoholics Chrysanthou-Piterou, M.
 2000
 47 8S1 p. S157-
1 p.
 artikel
255 201. Impact of familiarity and emotional attachment on the visual processing of faces Leibenluft, E.
 2000
 47 8S1 p. S61-
1 p.
 artikel
256 348. Impaired conflict-related activity in anterior cingulate in unmedicated schizophrenia Carter, C.S.
 2000
 47 8S1 p. S105-
1 p.
 artikel
257 276. Impaired facial fear recognition in manic but not euthymic bipolar patients Lembke, A.
 2000
 47 8S1 p. S83-S84
2 p.
 artikel
258 295. Impaired recollection memory but intact habit memory in unipolar depressed patients MacQueen, G.
 2000
 47 8S1 p. S89-
1 p.
 artikel
259 438. IMPASE-2 expression and altered calcium homeostasis phenotypes in bipolar I disorder Yoon, I-S
 2000
 47 8S1 p. S134-
1 p.
 artikel
260 340. Implicit versus explicit category learning: an event-related functional MRI study Aizenstein, H.J.
 2000
 47 8S1 p. S102-
1 p.
 artikel
261 476. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder Ströhle, A.
 2000
 47 8S1 p. S145-
1 p.
 artikel
262 237. Increased nonlinearity and decreased chaoticity of heart rate time series in patients with panic disorder Radha Krishna Rao, K.A.
 2000
 47 8S1 p. S72-
1 p.
 artikel
263 239. Increased QT variability in patients with panic disorder and depression Yeragani, V.K.
 2000
 47 8S1 p. S73-
1 p.
 artikel
264 Index 2000
 47 8S1 p. S174-S185
12 p.
 artikel
265 187. Indices of early dementia Haroutunian, V.
 2000
 47 8S1 p. S57-
1 p.
 artikel
266 562. Indices of early dementia: neocortical levels of amyloid β-peptide Buxbaum, J.D.
 2000
 47 8S1 p. S171-
1 p.
 artikel
267 560. Indices of early dementia: neuropathological indices Haroutunian, V.
 2000
 47 8S1 p. S171-
1 p.
 artikel
268 564. Indices of early dementia: neuropsychological and behavioral indices Mohs, R.C.
 2000
 47 8S1 p. S172-
1 p.
 artikel
269 106. Individual cognitive profile analysis in schizophrenia: evidence from a new sample Kremen, W.S.
 2000
 47 8S1 p. S32-
1 p.
 artikel
270 107. Individual cognitive profiles in schizophrenia: heterogeneity or change over time? Kremen, W.S.
 2000
 47 8S1 p. S32-
1 p.
 artikel
271 171. Information processing deficits in schizophrenia: effects of risperidone as compared to typical antipsychotics Kumari, V.
 2000
 47 8S1 p. S51-S52
2 p.
 artikel
272 74. Inhibitory deficits in state hospital schizophrenia patients Salo, R.
 2000
 47 8S1 p. S22-S23
2 p.
 artikel
273 39. Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro Kim, H.F.
 2000
 47 8S1 p. S12-
1 p.
 artikel
274 565. Integrated ERP/fMRI analysis of deviance processing in schizophrenia Turetsky, B.I.
 2000
 47 8S1 p. S172-
1 p.
 artikel
275 349. Intensity-dependent RCBF during 1hz RTMS over the left primary motor and prefrontal cortices Speer, A.M.
 2000
 47 8S1 p. S105-
1 p.
 artikel
276 410. Interactive effects in the anterior cingulate of sadness and selective attention: a PET study Liotti, M.
 2000
 47 8S1 p. S125-S126
2 p.
 artikel
277 358. Interregional associations of cerebral glucose metabolism in healthy adults Willis, M.W.
 2000
 47 8S1 p. S108-
1 p.
 artikel
278 519. Intraperitoneal administration of CCK-antisense oligodeoxynucleotides in rats—is it a new strategy as a treatment for anxiety? Cohen, H.
 2000
 47 8S1 p. S158-
1 p.
 artikel
279 447. In-vivo and in-vitro action of glucocorticoids on neuronal 5-lipoxygenase Uz, T.
 2000
 47 8S1 p. S137-
1 p.
 artikel
280 377. Involvement of the vagus nerves and associated CNS pathways in psychiatric disorders Faris, P.L.
 2000
 47 8S1 p. S115-
1 p.
 artikel
281 472. Ipsapirone as a serotonergic probe in personality disorder patients Reynolds, D.
 2000
 47 8S1 p. S144-
1 p.
 artikel
282 468. Irrelevant stimuli produce less phase resetting than relevant stimuli Jansen, B.H.
 2000
 47 8S1 p. S142-S143
2 p.
 artikel
283 275. Is olanzapine a mood-stabilizer? Tohen, M.F.
 2000
 47 8S1 p. S83-
1 p.
 artikel
284 387. Is the genetics of schizophrenia and bipolar disorder the genetics of neurodevelopment? Focus on transcriptional regulator genes Lesch, K.-P.
 2000
 47 8S1 p. S118-
1 p.
 artikel
285 558. Is transcranial magnetic stimulation as effective as electroconvulsive therapy in the treatment of severe major depression? Grunhaus, L.
 2000
 47 8S1 p. S170-
1 p.
 artikel
286 102. Kinetics and safety of a novel risperidone depot formulation Eerdekens, M.
 2000
 47 8S1 p. S31-
1 p.
 artikel
287 489. Laboratory measures of impulsivity in hospitalized adolescents with disruptive behavior disorders Bjork, J.M.
 2000
 47 8S1 p. S149-
1 p.
 artikel
288 503. Lateralization of TPT minicolumns in patients with schizophrenia Casanova, M.F.
 2000
 47 8S1 p. S153-
1 p.
 artikel
289 509. Lateral ventricular volume correlates in persons hypothetically at-risk for schizophrenia Bedwell, J.S.
 2000
 47 8S1 p. S154-S155
2 p.
 artikel
290 338. L-DOPA effect on connectivity within motor CSPTC loop in Parkinson’s disease Mentis, M.J
 2000
 47 8S1 p. S102-
1 p.
 artikel
291 463. Leucine-enkephalin metabolism in various patient populations. Drug effects Wolf, M.E.
 2000
 47 8S1 p. S141-
1 p.
 artikel
292 281. Li+ inhibits the NMDA-induced cytoplasmic [Ca2+] but not [Na+] transients Kiedrowski, L.
 2000
 47 8S1 p. S85-
1 p.
 artikel
293 211. Linear and non-linear models of brain interactions Büchel, C.
 2000
 47 8S1 p. S64-
1 p.
 artikel
294 142. Longitudinal study of basal ganglia volume in schizophrenic patients Corson, P.W.
 2000
 47 8S1 p. S43-
1 p.
 artikel
295 532. Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in patients with Alzheimer’s dementia Street, J.S.
 2000
 47 8S1 p. S162-
1 p.
 artikel
296 141. Long-term quetiapine for psychosis in Parkinson’s disease in place of other antipsychotics Juncos, J.L.
 2000
 47 8S1 p. S42-S43
2 p.
 artikel
297 140. Long-term treatment with quetiapine improves cognitive function in schizophrenia Purdon, S.E.
 2000
 47 8S1 p. S42-
1 p.
 artikel
298 62. Low levels of antibodies to cardiolipin in first episode and chronic schizophrenia Sirota, P.
 2000
 47 8S1 p. S19-
1 p.
 artikel
299 185. Magnetic stimulation of the brain: correlates of antidepressant response Grunhaus, L.
 2000
 47 8S1 p. S56-
1 p.
 artikel
300 181. Manifestations of dopamine and glutamate systems dysfunction in animal models Caron, M.G.
 2000
 47 8S1 p. S54-S55
2 p.
 artikel
301 485. MDMA (“ecstasy”) effects on sensorimotor gating after selective pretreatments in humans Liechti, M.E.
 2000
 47 8S1 p. S148-
1 p.
 artikel
302 303. Measurement of human cortical GABA synthesis in vivo Mason, G.F.
 2000
 47 8S1 p. S92-
1 p.
 artikel
303 411. Measurement of the rate of pyruvate carboxylase in human brain by 13C MRS Mason, G.F.
 2000
 47 8S1 p. S126-
1 p.
 artikel
304 563. Measuring and predicting functional outcomes in schizophrenia Brekke, J.S.
 2000
 47 8S1 p. S171-S172
2 p.
 artikel
305 179. Mechanism of peripheral noradrenergic stimulation by risperidone Elman, I.
 2000
 47 8S1 p. S54-
1 p.
 artikel
306 48. Medial temporal lobe memory system dysfunction in relatives of patients with schizophrenia Seidman, L.J.
 2000
 47 8S1 p. S15-
1 p.
 artikel
307 174. Medication effect in first episode schizophrenia measured by proton magnetic resonance spectroscopy Fannon, D.
 2000
 47 8S1 p. S52-S53
2 p.
 artikel
308 497. MEG and short-term memory in schizophrenia and schizoaffective disorder Reite, M.L.
 2000
 47 8S1 p. S151-
1 p.
 artikel
309 190. Membrane deficits in schizophrenia Yao, J.K.
 2000
 47 8S1 p. S58-
1 p.
 artikel
310 227. Menstrual-related changes in cortical excitability in women with PMS and controls Smith, M.J.
 2000
 47 8S1 p. S69-
1 p.
 artikel
311 462. Metalloproteinases activity in various neurological disorders Valenzuela, M.A.
 2000
 47 8S1 p. S141-
1 p.
 artikel
312 353. Methylphenidate dose-dependently alters blood flow in the vermis but not basal ganglia of ADHD boys Anderson, C.M.
 2000
 47 8S1 p. S106-S107
2 p.
 artikel
313 152. Mitochondrial dysfunction: a mechanism for tardive dyskinesia Brennan Jr., W.A.
 2000
 47 8S1 p. S46-
1 p.
 artikel
314 293. Modafinil augmentation of antidepressant treatment in depression Menza, M.
 2000
 47 8S1 p. S89-
1 p.
 artikel
315 404. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and schizotypal subjects: evidence of inhibitory deficits Cadenhead, K.S.
 2000
 47 8S1 p. S123-S124
2 p.
 artikel
316 31. Molecular characterization of the autistic brain using the high-density microarray technique Ho, L.
 2000
 47 8S1 p. S9-
1 p.
 artikel
317 229. Molecular cloning and characterization of a novel lithium-regulated gene in rat brain Hua, L.V.
 2000
 47 8S1 p. S70-
1 p.
 artikel
318 186. Molecular genetics of substance abuse: analyzing complex traits Goldman, D.
 2000
 47 8S1 p. S56-S57
2 p.
 artikel
319 196. Mood stabilizers increase neurogenesis and neurite outgrowth Chen, G.
 2000
 47 8S1 p. S60-
1 p.
 artikel
320 38. Motor programming deficits in depression: support for a dopaminergic mechanism Caligiuri, M.P.
 2000
 47 8S1 p. S11-S12
2 p.
 artikel
321 403. Mouse genetic models for sensorimotor gating deficits Paylor, R.
 2000
 47 8S1 p. S123-
1 p.
 artikel
322 183. Mouse models of Huntington’s disease Ross, C.A.
 2000
 47 8S1 p. S55-
1 p.
 artikel
323 351. MRI abnormalities in first-episode schizophrenia patients through image averaging Keshavan, M.S.
 2000
 47 8S1 p. S106-
1 p.
 artikel
324 43. MRI analysis of children at risk for bipolar disorder DelBello, M.P.
 2000
 47 8S1 p. S13-
1 p.
 artikel
325 343. MRI investigation of cerebellar abnormalities in bipolar disorder Brambilla, P.
 2000
 47 8S1 p. S103-
1 p.
 artikel
326 345. MRI study of the cingulate cortex in bipolar disorder patients Figueroa, R.
 2000
 47 8S1 p. S104-
1 p.
 artikel
327 136. Muscarinic receptor protein and mRNA in DLPFC of schizophrenia and affective disorder Crook, J.M.
 2000
 47 8S1 p. S41-
1 p.
 artikel
328 368. Muscarinic 2 receptors in cognitively normal young and old volunteers Podruchny, T.A.
 2000
 47 8S1 p. S111-
1 p.
 artikel
329 109. N100 and P300 ERP abnormalities in schizophrenia and epilepsy Mathalon, D.H.
 2000
 47 8S1 p. S33-
1 p.
 artikel
330 182. Narcolepsy and hypocretins (orexins) Mignot, E.
 2000
 47 8S1 p. S55-
1 p.
 artikel
331 390. Neonatal damage of the rat hippocampus results in a constellation of schizophrenia- like phenomena Lipska, B.K.
 2000
 47 8S1 p. S119-
1 p.
 artikel
332 172. Neural correlates of procedural learning: a functional MRI study Kumari, V.
 2000
 47 8S1 p. S52-
1 p.
 artikel
333 9. Neurochemical brain imaging findings in mood disorders Soares, J.C.
 2000
 47 8S1 p. S3-
1 p.
 artikel
334 77. Neurocognitive findings in schizophrenic subjects with above average IQ Vinogradov, S.
 2000
 47 8S1 p. S23-
1 p.
 artikel
335 108. Neurocognitive predictors of functional decline in poor-outcome schizophrenia Moriarty, P.J.
 2000
 47 8S1 p. S33-
1 p.
 artikel
336 231. Neuroendocrine and psychobiological responses to uncontrollable stress Morgan III, C.A.
 2000
 47 8S1 p. S70-
1 p.
 artikel
337 449. Neuroendocrine correlates of personality traits Goodman, M.
 2000
 47 8S1 p. S137-
1 p.
 artikel
338 500. Neurofibrillary tangles and pyramidal cell counts in paraphrenia Casanova, M.F.
 2000
 47 8S1 p. S152-
1 p.
 artikel
339 25. Neurogenetics of FTD—recent developments Geschwind, D.
 2000
 47 8S1 p. S7-
1 p.
 artikel
340 2. Neuroimaging in the postgenome era Weinberger, D.R.
 2000
 47 8S1 p. S1-
1 p.
 artikel
341 311. Neuronavigated transcranial magnetic stimulation in depression Herwig, U.
 2000
 47 8S1 p. S94-
1 p.
 artikel
342 483. Neuropharmacology in adult drosophila: studies of drug tolerance Manev, H.
 2000
 47 8S1 p. S147-
1 p.
 artikel
343 67. Neuroprotective actions of olanzapine in rat: cholinergic function Mahadik, S.P.
 2000
 47 8S1 p. S20-S21
2 p.
 artikel
344 68. Neuroprotective actions of olanzapine in rat: mechanism Mahadik, S.P.
 2000
 47 8S1 p. S21-
1 p.
 artikel
345 94. Neuropsychological correlates of mesiotemporal volumes in schizophrenia Szeszko, P.R.
 2000
 47 8S1 p. S28-S29
2 p.
 artikel
346 82. Neuropsychological evaluations of high risk adolescents for schizophrenia Tibbo, P.
 2000
 47 8S1 p. S25-
1 p.
 artikel
347 66. Neuropsychological function during smoking cessation in schizophrenia George, T.P.
 2000
 47 8S1 p. S20-
1 p.
 artikel
348 244. Neuropsychological function in drug-free depressives Young, A.H.
 2000
 47 8S1 p. S74-
1 p.
 artikel
349 416. Neuropsychology of obsessive compulsive disorder Khanna, S.
 2000
 47 8S1 p. S127-
1 p.
 artikel
350 15. Neurosteroids in reproductive endocrine-related mood disorders Daly, R.C.
 2000
 47 8S1 p. S5-
1 p.
 artikel
351 282. New cholinergic test of sleep/mood dysregulation in familial depression Giles, D.E.
 2000
 47 8S1 p. S85-
1 p.
 artikel
352 11. New directions in cortical electrophysiology: from basic neuroscience to clinical research Bruder, G.E.
 2000
 47 8S1 p. S4-
1 p.
 artikel
353 426. New-onset diabetes and ketoacidosis with atypical antipsychotics Wilson, D.R.
 2000
 47 8S1 p. S130-S131
2 p.
 artikel
354 496. Nicotine, mecamylamine, and movement disorders in smokers with schizophrenia Webber, M.A.
 2000
 47 8S1 p. S151-
1 p.
 artikel
355 160. Nicotine replacement and smoking suppression in schizophrenia Dalack, G.W.
 2000
 47 8S1 p. S48-
1 p.
 artikel
356 544. Nicotinic acetycholine receptors in Flinders Rat Lines Auta, J.
 2000
 47 8S1 p. S165-S166
2 p.
 artikel
357 177. NMDA and 5-HT2A receptor dysfunction in working memory deficits in schizophrenia Umbricht, D.
 2000
 47 8S1 p. S53-
1 p.
 artikel
358 567. NMDA-mediated neurophysiologic deficits in schizophrenia Javitt, D.C.
 2000
 47 8S1 p. S173-
1 p.
 artikel
359 178. NMDA receptor dysfunction and abnormal information encoding Umbricht, D.
 2000
 47 8S1 p. S54-
1 p.
 artikel
360 470. No increased severity of neuropathologic features in Alzheimer’s disease with psychosis Sweet, R.A.
 2000
 47 8S1 p. S143-
1 p.
 artikel
361 236. Noise effects in a neurodynamical model for disease states of mood disorders Huber, M.T.
 2000
 47 8S1 p. S72-
1 p.
 artikel
362 8. Nuts and bolts magnetic resonance spectroscopy: a guide to quantitative measurement of cerebral neurochemistry Moore, G.J.
 2000
 47 8S1 p. S3-
1 p.
 artikel
363 541. Obsessive-compulsive disorder and Parkinson’s disease Maia, A.S.S.F.
 2000
 47 8S1 p. S165-
1 p.
 artikel
364 510. Olanzapine and clozapine elevate prolactin levels after every daily dose Turrone, P.
 2000
 47 8S1 p. S155-
1 p.
 artikel
365 533. Olanzapine in the prevention of psychosis among nursing home patients with behavioral disturbances associated with Alzheimer’s disease Clark, W.S.
 2000
 47 8S1 p. S162-
1 p.
 artikel
366 280. Olanzapine therapy for posttraumatic stress disorder Petty, F.
 2000
 47 8S1 p. S85-
1 p.
 artikel
367 114. Ondansetron improves P50 auditory sensory gating in medicated schizophrenic patients Adler, L.E.
 2000
 47 8S1 p. S35-
1 p.
 artikel
368 401. One Hertz rTMS of left temporoparietal cortex in schizophrenic patients reporting auditory hallucinations Hoffman, R.E.
 2000
 47 8S1 p. S122-S123
2 p.
 artikel
369 277. Open adjunctive gabapentin effective in bipolar depression Wang, P.W.
 2000
 47 8S1 p. S84-
1 p.
 artikel
370 460. Opioid abnormalities in alcoholism: naltrexone induced responses Farren, C.K.
 2000
 47 8S1 p. S140-
1 p.
 artikel
371 531. Oral MG2+-supplementation affects sleep-endocrine function in elderly Held, K.
 2000
 47 8S1 p. S161-S162
2 p.
 artikel
372 133. P300 amplitude for affective vs. visual categorization in cannabis smokers in relation to schizotypy Skosnik, P.D.
 2000
 47 8S1 p. S40-
1 p.
 artikel
373 484. Parasympathetic rebound following stress in four rat strains Djuric, V.J.
 2000
 47 8S1 p. S147-S148
2 p.
 artikel
374 346. Parsing executive processes: control vs evaluation in the frontal cortex Carter, C.S.
 2000
 47 8S1 p. S104-
1 p.
 artikel
375 436. Pathological dissociation in borderline personality disorder—the role of childhood trauma and serotonergic genes Goodman, M.
 2000
 47 8S1 p. S133-S134
2 p.
 artikel
376 189. Pediatric psychopharmacology: NIMH-sponsored multisite studies Riddle, M.A.
 2000
 47 8S1 p. S57-S58
2 p.
 artikel
377 434. Peptide nucleic acids targeted to the dopamine transporter alter behavior Tyler, B.M.
 2000
 47 8S1 p. S133-
1 p.
 artikel
378 88. Perceptual deficits in schizophrenia may be explained by aberrant gamma range oscillations Green, M.F.
 2000
 47 8S1 p. S27-
1 p.
 artikel
379 465. Personality traits are correlated with motor cortex excitability: a transcranial magnetic stimulation (TMS) study Nguyen, M.
 2000
 47 8S1 p. S142-
1 p.
 artikel
380 20. PET imaging of serotonin responsivity: relationship to mood and impulsivity Mann, J.J.
 2000
 47 8S1 p. S5-S6
2 p.
 artikel
381 356. PET receptor studies of major depression with anger attacks Dougherty, D.D.
 2000
 47 8S1 p. S107-S108
2 p.
 artikel
382 1. Pharmacogenomics Weinshilboum, R.
 2000
 47 8S1 p. S1-
1 p.
 artikel
383 435. Pharmacokinetics of peptide nucleic acids after IV administration Jansen, K.
 2000
 47 8S1 p. S133-
1 p.
 artikel
384 548. Pharmacokinetics of risperidone/donepezil combination Pesco-Koplowitz, L.
 2000
 47 8S1 p. S167-
1 p.
 artikel
385 529. Pharmacokinetics of rivastigmine and its metabolite in patients with Alzheimer’s disease Cutler, N.R.
 2000
 47 8S1 p. S161-
1 p.
 artikel
386 83. Pharmacology of psychotic-like abnormalities expressed by reeler heterozygous mouse Tueting, P.
 2000
 47 8S1 p. S25-
1 p.
 artikel
387 557. Phase resetting of background EEG is a major EP generation mechanism Jansen, B.H.
 2000
 47 8S1 p. S170-
1 p.
 artikel
388 550. Phenotypic assessment of cocaine-induced paranoia and psychotic symptoms (CIPPS) Cubells, J.F.
 2000
 47 8S1 p. S167-S168
2 p.
 artikel
389 444. Phenylethanolamine N-methyltransferase gene: neural signalling mechanism Wong, D.L.
 2000
 47 8S1 p. S136-
1 p.
 artikel
390 554. Physical activity, combined with the norepinephrine-selective antidepressant reboxetine, rapidly potentiates BDNF mRNA expression in the rat hippocampus Russo-Neustadt, A.
 2000
 47 8S1 p. S169-
1 p.
 artikel
391 290. PIP2 platelet membrane levels: a marker of relevance for the pathophysiology of bipolar disorder? Soares, J.C.
 2000
 47 8S1 p. S88-
1 p.
 artikel
392 516. Plasma GABA is inversely correlated with self-reported hostility: a preliminary report Bjork, J.M.
 2000
 47 8S1 p. S157-
1 p.
 artikel
393 253. Platelet activation in treatment responders vs. nonresponders in patients with major depression Mussleman, D.L.
 2000
 47 8S1 p. S77-
1 p.
 artikel
394 252. Platelet activation of depressed patients in comparison to patients with aortic atherosclerosis Musselman, D.L.
 2000
 47 8S1 p. S76-S77
2 p.
 artikel
395 65. 31P NMR of phospholipids in postmortem schizophrenic brains Komoroski, R.A.
 2000
 47 8S1 p. S20-
1 p.
 artikel
396 339. Posterior cortical white matter anomalies in velocardiofacial syndrome Kates, W.R.
 2000
 47 8S1 p. S102-
1 p.
 artikel
397 118. PPI in unmedicated and medicated acutely psychotic schizophrenia patients Perry, W.
 2000
 47 8S1 p. S36-
1 p.
 artikel
398 279. Pramipexole and learned helplessness Petty, F.
 2000
 47 8S1 p. S84-S85
2 p.
 artikel
399 283. Predicting global severity of depression from individual BDI and HRS-D items Sharpe, M.C.
 2000
 47 8S1 p. S86-
1 p.
 artikel
400 284. Predicting suicidal ideation from individual items on the BDI and HRS-D Sharpe, M.C.
 2000
 47 8S1 p. S86-
1 p.
 artikel
401 406. Prefrontal cell pathology distinguishes bipolar disorder from schizophrenia Rajkowska, G.
 2000
 47 8S1 p. S124-
1 p.
 artikel
402 312. Prefrontal cortex, serotonin, and ECT/TMS Juckel, G.
 2000
 47 8S1 p. S94-
1 p.
 artikel
403 486. Prefrontal modulation of mood and emotionally induced facial expressions: a TMS study Padberg, F.
 2000
 47 8S1 p. S148-
1 p.
 artikel
404 198. Programs of gene expression in human fibroblasts from patients with major depression Rossby, S.P.
 2000
 47 8S1 p. S60-S61
2 p.
 artikel
405 248. Protein kinase A in the postmortem brain of suicide victims Dwivedi, Y.
 2000
 47 8S1 p. S75-
1 p.
 artikel
406 457. P50 sensory gating has a normal distribution in normal adults Campbell, D.
 2000
 47 8S1 p. S139-
1 p.
 artikel
407 5. Psychiatry in the new millennium Hyman, S.E.
 2000
 47 8S1 p. S2-
1 p.
 artikel
408 459. Psycho-biological indices of special operations selection Morgan III, C.A.
 2000
 47 8S1 p. S140-
1 p.
 artikel
409 542. Psychomotor aspects of mood disorders in Parkinson’s disease Marsh, L.
 2000
 47 8S1 p. S165-
1 p.
 artikel
410 310. Psychotic depression, hypercortisolemia and mortality Narayan, M.
 2000
 47 8S1 p. S94-
1 p.
 artikel
411 369. Psychotropic drug naive and currently treated patients with Tourette syndrome: a [123I]-β-CIT SPECT-study Schindler, S.D.
 2000
 47 8S1 p. S111-S112
2 p.
 artikel
412 408. Putative role of allopregnanolone in psychiatric disorders Guidotti, A.
 2000
 47 8S1 p. S125-
1 p.
 artikel
413 448. Putative role of 5-lipoxygenase (5-LOX) in neurogenesis Manev, H.
 2000
 47 8S1 p. S137-
1 p.
 artikel
414 224. Putative thalamic terminals are decreased in the prefrontal cortex in schizophrenia Cruz, D.A.
 2000
 47 8S1 p. S68-
1 p.
 artikel
415 379. 22q11 deletion syndrome (velocardiofacial syndrome) and schizophrenia: a genetic subtype? Nicolson, R.
 2000
 47 8S1 p. S115-S116
2 p.
 artikel
416 301. Quantitative MRI in bipolar and schizophrenic patients Schnur, D.B.
 2000
 47 8S1 p. S91-
1 p.
 artikel
417 535. Quetiapine for the treatment of psychosis in Lewy body disease Parsa, M.A.
 2000
 47 8S1 p. S163-
1 p.
 artikel
418 524. Randomized trial of supplemental EPA for residual symptoms of schizophrenia Fenton, W.S.
 2000
 47 8S1 p. S159-S160
2 p.
 artikel
419 76. Reaction time slowing in schizophrenia: domain-specific features Minzenberg, M.J.
 2000
 47 8S1 p. S23-
1 p.
 artikel
420 418. Reactivation of herpes simplex virus infection in schizophrenia Janakiramaiah, N.
 2000
 47 8S1 p. S128-
1 p.
 artikel
421 305. Reduced cortical GABA in depression is not due to decreased gray matter Sanacora, G.
 2000
 47 8S1 p. S92-
1 p.
 artikel
422 37. Reduced expression of PKC isozymes in the brains of teenage suicide victims Pandey, G.N.
 2000
 47 8S1 p. S11-
1 p.
 artikel
423 359. Reduced hippocampal volume in association with P50 nonsuppression following traumatic brain injury Arciniegas, D.B.
 2000
 47 8S1 p. S108-S109
2 p.
 artikel
424 44. Reduced left Heschl’s gyrus volume in schizotypal personality disorder Dickey, C.C.
 2000
 47 8S1 p. S13-S14
2 p.
 artikel
425 502. Reduced neuropil in the auditory cortex of patients with schizophrenia Casanova, M.F.
 2000
 47 8S1 p. S152-S153
2 p.
 artikel
426 417. Reduced Purkinje cell size in autistic cerebellum Fatemi, S.H.
 2000
 47 8S1 p. S128-
1 p.
 artikel
427 534. Reduction of psychotic symptoms in patients with Lewy body-like symptoms treated with olanzapine Clark, W.S.
 2000
 47 8S1 p. S163-
1 p.
 artikel
428 223. Reelin and GAD67 downregulation and psychosis vulnerability Costa, E.
 2000
 47 8S1 p. S68-
1 p.
 artikel
429 474. Reelin, a protein regulating neural development, is expressed in the blood in adult mammals Smalheiser, N.R.
 2000
 47 8S1 p. S144-S145
2 p.
 artikel
430 318. Regression-based volume adjustments for subcortical structures Ha, K.
 2000
 47 8S1 p. S96-
1 p.
 artikel
431 197. Regulation of mood stabilizer regulated genes Wang, J.F.
 2000
 47 8S1 p. S60-
1 p.
 artikel
432 482. Regulation of NR1 NMDA receptor splice variant expression in rat hippocampus Healy, D.J.
 2000
 47 8S1 p. S147-
1 p.
 artikel
433 120. Regulation of sensorimotor gating in rats by hippocampal NMDA: anatomical localization Hanlon, F.M.
 2000
 47 8S1 p. S36-S37
2 p.
 artikel
434 101. Relapse prevention with olanzapine Beasley Jr., C.M.
 2000
 47 8S1 p. S31-
1 p.
 artikel
435 540. Relative hypoferremia and benign transient hyperthermia in zuclopenthixol-acetat treatment Conca, A.
 2000
 47 8S1 p. S164-
1 p.
 artikel
436 254. Repeated social stress induces prolonged FOS expression in limbic cortex Nikulina, E.M.
 2000
 47 8S1 p. S77-
1 p.
 artikel
437 245. Repetitive transcranial magnetic stimulation—evidence for antidepressant-like and neuroprotective effects Keck, M.E.
 2000
 47 8S1 p. S74-S75
2 p.
 artikel
438 364. Reproducibility of water acquired 1H-MRSI data in healthy subjects Bertolino, A.
 2000
 47 8S1 p. S110-
1 p.
 artikel
439 518. Respiratory irregularity in panic patients may reflect excessive sighing Abelson, J.L.
 2000
 47 8S1 p. S157-S158
2 p.
 artikel
440 504. Restricted limbic tauopathy in patients with late onset schizophrenia Casanova, M.F.
 2000
 47 8S1 p. S153-
1 p.
 artikel
441 28. Rett syndrome and beyond: recurrent spontaneous and familial mutations at CpG hotspots in the methyl-CpG binding protein-2 gene Francke, U.
 2000
 47 8S1 p. S8-
1 p.
 artikel
442 450. Reversal of lidocaine induced delirium with physostigmine Tseng, K.-H.
 2000
 47 8S1 p. S137-S138
2 p.
 artikel
443 27. Reversal of spontaneous atrophy of cholinergic basal forebrain neurons in the aged primate by ex vivo gene therapy Smith, D.E.
 2000
 47 8S1 p. S7-S8
2 p.
 artikel
444 52. Reverse pharmacogenetics: a new approach to rapid relapse in schizophrenia? Malhotra, A.K.
 2000
 47 8S1 p. S16-
1 p.
 artikel
445 151. Right anterior cingulate metabolic abnormality in chronic paranoid schizophrenia Nordahl, T.E.
 2000
 47 8S1 p. S45-S46
2 p.
 artikel
446 263. Risk factors for postpartum blues in Israeli women Bloch, M.
 2000
 47 8S1 p. S80-
1 p.
 artikel
447 546. Risperidone in the treatment of schizotypal personality disorder Koenigsberg, H.W.
 2000
 47 8S1 p. S166-
1 p.
 artikel
448 130. Risperidone is associated with better work recovery after onset of schizophrenia Nuechterlein, K.H.
 2000
 47 8S1 p. S39-
1 p.
 artikel
449 175. Risperidone, olanzapine, phenotiazines and neurosychological tests in schizophrenia Rybakowski, J.K.
 2000
 47 8S1 p. S53-
1 p.
 artikel
450 427. Risperidone oral solution versus intramuscular haloperidol for control of psychotic agitation Currier, G.W.
 2000
 47 8S1 p. S131-
1 p.
 artikel
451 490. Risperidone versus placebo for severe conduct disorder in children with mental retardation Aman, M.
 2000
 47 8S1 p. S149-
1 p.
 artikel
452 104. Risperidone vs haloperidol for relapse prevention in schizophrenia and schizoaffective disorder: a long-term double-blind comparison Csernansky, J.G.
 2000
 47 8S1 p. S31-S32
2 p.
 artikel
453 105. Risperidone vs. olanzapine in patients with schizophrenia and schizoaffective disorder Conley, R.R.
 2000
 47 8S1 p. S32-
1 p.
 artikel
454 431. Role of polymorphisms in serotonin genes in PMDD Roca, C.A.
 2000
 47 8S1 p. S132-
1 p.
 artikel
455 453. rTMS induced epileptic discharge; a report of one case Boutros, N.N.
 2000
 47 8S1 p. S138-S139
2 p.
 artikel
456 267. rTMS treatment of PTSD and major depression Rosenberg, P.B.
 2000
 47 8S1 p. S81-
1 p.
 artikel
457 125. Saccadic disinhibition in schizophrenia patients and their relatives: the effects of increasing inhibitory load Curtis, C.E.
 2000
 47 8S1 p. S38-
1 p.
 artikel
458 478. Saccadic eye movement responses to DHEA & alprazolam in patients with adrenal insuffiency Fabian, T.J.
 2000
 47 8S1 p. S146-
1 p.
 artikel
459 99. Safety and effectiveness of olanzapine versus other antipsychotic drugs in the treatment of outpatients with schizophrenia Gomez, J.C.
 2000
 47 8S1 p. S30-
1 p.
 artikel
460 549. Salivary cortisol responsivity: emotional stress, memory, and prior emotional trauma Nejtek, V.A.
 2000
 47 8S1 p. S167-
1 p.
 artikel
461 507. Schizophrenia patients and normal controls demonstrate a similar effect of sex on prepulse inhibition of the startle reflex Ellwanger, J.
 2000
 47 8S1 p. S154-
1 p.
 artikel
462 221. Schizophrenia: the identification of genetic subgroups Pulver, A.E.
 2000
 47 8S1 p. S67-
1 p.
 artikel
463 360. Seasonal variation of central 5-HTT availability in healthy females Praschak-Rieder, N.
 2000
 47 8S1 p. S109-
1 p.
 artikel
464 455. Sensory gating in older healthy adults Boutros, N.N.
 2000
 47 8S1 p. S139-
1 p.
 artikel
465 381. Sensory gating: new vistas Boutros, N.N.
 2000
 47 8S1 p. S116-
1 p.
 artikel
466 3. Sequencing and combining treatments: can the art become a science? Rush, A.J.
 2000
 47 8S1 p. S1-
1 p.
 artikel
467 473. Sequential memory in musicians & non-musicians; implication for the development of the planum temporale Duncan, A.
 2000
 47 8S1 p. S144-
1 p.
 artikel
468 22. Serotonergic responsiveness in impulsive/aggressive personality disorders Siever, L.J.
 2000
 47 8S1 p. S6-
1 p.
 artikel
469 389. Serotonin-related genes and impulsive aggression in personality disorders New, A.S.
 2000
 47 8S1 p. S118-
1 p.
 artikel
470 34. Serotonin transporter genotypes, CSF 5HIAA, and cardiovascular reactivity to stress Williams, R.B.
 2000
 47 8S1 p. S10-
1 p.
 artikel
471 306. SERT genotype influence in fluoxetine antidepressant response: a study of initial conditions Rausch, J.L.
 2000
 47 8S1 p. S92-S93
2 p.
 artikel
472 12. Sex and brain development Rubinow, D.R.
 2000
 47 8S1 p. S4-
1 p.
 artikel
473 129. Sex differences in the corpus callosum of chronically ill schizophrenic patients Hoff, A.L.
 2000
 47 8S1 p. S39-
1 p.
 artikel
474 321. Sexual dimorphism in the induction of feelings of loss: a pilot fMRI study MacMaster, F.P.
 2000
 47 8S1 p. S96-S97
2 p.
 artikel
475 511. Significant differences between occupancy measured with radioligand vs. EEDQ Barsoum, S.C.
 2000
 47 8S1 p. S155-
1 p.
 artikel
476 268. Simultaneous catecholamine and indoleamine depletion in unmedicated depressed subjects Berman, R.M.
 2000
 47 8S1 p. S81-
1 p.
 artikel
477 192. Single cell microarray analysis of multigenic diseases Eberwine, J.
 2000
 47 8S1 p. S58-S59
2 p.
 artikel
478 216. Six-month outcome of electroconvulsive therapy and repetitive transcranial magnetic stimulation therapy Dannon, P.N.
 2000
 47 8S1 p. S66-
1 p.
 artikel
479 264. Sleep-endocrine effects of GHRH in depression are sexually dimorphic Antonijevic, I.A.
 2000
 47 8S1 p. S80-
1 p.
 artikel
480 40. Smoking and panic disorder: an epidemiologic investigation Breslau, N.
 2000
 47 8S1 p. S12-
1 p.
 artikel
481 95. Smooth pursuit eye movement dysfunction in patients at clinical risk for schizophrenia Obuchowski, M.
 2000
 47 8S1 p. S29-
1 p.
 artikel
482 341. Specificity of reduced cortical gray matter to first episode schizophrenic psychosis Hirayasu, Y.
 2000
 47 8S1 p. S102-S103
2 p.
 artikel
483 512. Stability of prepulse inhibition of the acoustic startle reflex in schizophrenia Ludewig, K.
 2000
 47 8S1 p. S155-
1 p.
 artikel
484 405. Startle habituation and prepulse inhibition studies in mutant mice Geyer, M.A.
 2000
 47 8S1 p. S124-
1 p.
 artikel
485 419. Striatal D2 blockade and depression in schizophrenia—SPET findings Bressan, R.A.
 2000
 47 8S1 p. S128-
1 p.
 artikel
486 47. Striatal D2 receptor blockade predicted EPS with novel antipsychotics: a [123I] IBZM SPECT Tauscher, J.
 2000
 47 8S1 p. S14-
1 p.
 artikel
487 505. Striatal preprosomatostatin mRNA in schizophrenia Bachus, S.E.
 2000
 47 8S1 p. S153-
1 p.
 artikel
488 394. Structural MR imaging findings in schizotypal personality disorder subjects McCarley, R.W.
 2000
 47 8S1 p. S120-
1 p.
 artikel
489 138. Studies of molecular mechanisms regulating reelin gene expression Grayson, D.R.
 2000
 47 8S1 p. S41-S42
2 p.
 artikel
490 214. Studies of prefrontal cortical functional connectivity in schizophrenia Weinberger, D.R.
 2000
 47 8S1 p. S65-
1 p.
 artikel
491 199. Studies of traumatic grief: criteria, risks, outcomes Prigerson, Holly G.
 2000
 47 8S1 p. S61-
1 p.
 artikel
492 213. Study of anatomical connectivity with TMS-PET in intact humans Cohen, L.G.
 2000
 47 8S1 p. S65-
1 p.
 artikel
493 79. Subcortical brain abnormalities in patients with schizophrenia: an MRI morphometric study Seidman, L.J.
 2000
 47 8S1 p. S24-
1 p.
 artikel
494 334. Subcortical dopaminergic activity in schizotypal personality disorder Koenigsberg, H.W.
 2000
 47 8S1 p. S100-S101
2 p.
 artikel
495 220. Subjective effects of MDMA and MCPP: a human dose run-up study Tancer, M.E.
 2000
 47 8S1 p. S67-
1 p.
 artikel
496 551. Suicide attempts, impulsivity, and low serum cholesterol levels in male patients Diaz-Sastre, C.
 2000
 47 8S1 p. S168-
1 p.
 artikel
497 119. Sustained haloperidol opposes apomorphine and phencyclidine-induced startle gating deficits Martinez, Z.A.
 2000
 47 8S1 p. S36-
1 p.
 artikel
498 421. Symptoms associated with amygdaloid activity in schizophrenia Taylor, S.F.
 2000
 47 8S1 p. S129-
1 p.
 artikel
499 150. Talairach altas-based volumetric analysis of the brain in schizophrenia Johnson, C.
 2000
 47 8S1 p. S45-
1 p.
 artikel
500 212. Task-independent and task-dependent disturbances in functional connectivity in schizophrenia: pet studies Meyer-Lindenberg, A
 2000
 47 8S1 p. S64-S65
2 p.
 artikel
501 400. Temporal lobe responses to speech probes in schizophrenia Ford, J.M.
 2000
 47 8S1 p. S122-
1 p.
 artikel
502 112. Temporal lobe volume in schizotypal personality disorder and schizophrenia Downhill Jr., J.E.
 2000
 47 8S1 p. S34-
1 p.
 artikel
503 363. Test-retest reliability of brain SPECT studies in normals Konopka, L.M.
 2000
 47 8S1 p. S110-
1 p.
 artikel
504 488. Thalamic volume in pediatric obsessive compulsive disorder Rosenberg, D.R.
 2000
 47 8S1 p. S148-S149
2 p.
 artikel
505 352. Thalamic volumes in first episode schizophrenic patients Gilbert, A.
 2000
 47 8S1 p. S106-
1 p.
 artikel
506 292. The antidepressant activity of citalopram resides in the S- enantiomer (Lu 26-054) Sánchez, C.
 2000
 47 8S1 p. S88-S89
2 p.
 artikel
507 42. The contribution of orbitofrontal cortex to episodic memory impairment in OCD Savage, C.R.
 2000
 47 8S1 p. S13-
1 p.
 artikel
508 116. The effects of aging in schizophrenia on an antisaccade eye movement task Olincy, A.
 2000
 47 8S1 p. S35-
1 p.
 artikel
509 249. The effects of gender and the estrous cycle on learned helplessness in the rat Jenkins, J.A.
 2000
 47 8S1 p. S76-
1 p.
 artikel
510 132. The effects of temporal and spatial distractors on working memory function in schizophrenia Clark, G.
 2000
 47 8S1 p. S40-
1 p.
 artikel
511 184. The expanding world of ataxias Pulst, S.M.
 2000
 47 8S1 p. S55-S56
2 p.
 artikel
512 97. The hillside RAPP clinic: why the sudden interest in the schizophrenia prodrome? Cornblatt, B.
 2000
 47 8S1 p. S29-S30
2 p.
 artikel
513 439. The identification and localization of ER stress proteins as valproate regulated genes Bown, C.D.
 2000
 47 8S1 p. S134-
1 p.
 artikel
514 127. The identification of a putative 60 kDa autoantibody in schizophrenia Rapaport, M.H.
 2000
 47 8S1 p. S38-S39
2 p.
 artikel
515 103. The implications of antipsychotic treatment patterns on health outcomes in schizophrenia Engelhart, L.
 2000
 47 8S1 p. S31-
1 p.
 artikel
516 530. The influence of age on the response of major depression to electroconvulsive therapy O’Connor, K.
 2000
 47 8S1 p. S161-
1 p.
 artikel
517 10. The interaction between the immune system and psychiatric disorders Rapaport, M.H.
 2000
 47 8S1 p. S4-
1 p.
 artikel
518 124. The multiple dimensions of schizotypy in the biological relatives of schizophrenia patients Calkins, M.E.
 2000
 47 8S1 p. S38-
1 p.
 artikel
519 217. The neurobehavioral phenotype of the 22Q11.2 deletion syndrome Bearden, C.E.
 2000
 47 8S1 p. S66-
1 p.
 artikel
520 26. The pathobiology of tau protein in neurodegenerative diseases Nixon, R.A.
 2000
 47 8S1 p. S7-
1 p.
 artikel
521 146. The primate mediodorsal thalamic nucleus: effects of chronic haloperidol Pierri, J.N.
 2000
 47 8S1 p. S44-
1 p.
 artikel
522 261. Therapeutic efficacy of rTMS versus antidepressants in major depression Klein, E.
 2000
 47 8S1 p. S79-
1 p.
 artikel
523 319. The role of hippocampus and amygdala in schizophrenia, an MRI study Rajarethinam, R.P.
 2000
 47 8S1 p. S96-
1 p.
 artikel
524 440. The role of serotonin transporter gene in antidepressant-induced mania in bipolar patients Mundo, E.
 2000
 47 8S1 p. S135-
1 p.
 artikel
525 442. The segregation of HOPA mutations with hypothyroidism in a cohort of schizophrenic families Philibert, R.A.
 2000
 47 8S1 p. S135-
1 p.
 artikel
526 291. The S-enantiomer of citalopram (Lu 26-054) is a highly selective and potent serotonin reuptake inhibitor Sánchez, C.
 2000
 47 8S1 p. S88-
1 p.
 artikel
527 256. The serotonin transporter gene influences seasonality independently of personality Sher, L.
 2000
 47 8S1 p. S78-
1 p.
 artikel
528 566. The temporal relationship of cognitive and functional decline in poor outcome schizophrenia Friedman, J.I.
 2000
 47 8S1 p. S172-S173
2 p.
 artikel
529 467. The tremorometer: a portable instrument for quantifying hand tremor Caligiuri, M.P.
 2000
 47 8S1 p. S142-
1 p.
 artikel
530 163. Third ventricle enlargement and developmental delay in first episode schizophrenia Fannon, D.
 2000
 47 8S1 p. S49-
1 p.
 artikel
531 69. Thought disorder and language in schizotypal personality disorder Voglmaier, M.M.
 2000
 47 8S1 p. S21-
1 p.
 artikel
532 242. Thyroid axis activity in depressed inpatients Duval, F.
 2000
 47 8S1 p. S74-
1 p.
 artikel
533 241. Thyroid axis dysfunction is related to the longitudinal course of depression Duval, F.
 2000
 47 8S1 p. S73-
1 p.
 artikel
534 257. Thyroid function tests in patients with seasonal affective disorder and control subjects Sher, L.
 2000
 47 8S1 p. S78-
1 p.
 artikel
535 234. Thyroid hormone levels and recurrence in major depression Joffe, R.T.
 2000
 47 8S1 p. S71-
1 p.
 artikel
536 354. Tissue volume corrected hippocampal NAA is reduced in schizophrenia Pegues, M.
 2000
 47 8S1 p. S107-
1 p.
 artikel
537 54. Touch feel illusion in schizophrenic patients Peled, A.
 2000
 47 8S1 p. S17-
1 p.
 artikel
538 121. Towards the genetics of a complex phenotype: strain analyses of drug effects on startle gating Swerdlow, N.R.
 2000
 47 8S1 p. S37-
1 p.
 artikel
539 556. Transcranial magnetic stimulation studies of cortical excitability in depression Maeda, F.
 2000
 47 8S1 p. S169-S170
2 p.
 artikel
540 430. Transductional mechanisms and gene expression in melancholia Shelton, R.C.
 2000
 47 8S1 p. S132-
1 p.
 artikel
541 371. Transient d2 dopamine receptor occupancy in low EPS-incidence drugs: PET evidence Jones, C.
 2000
 47 8S1 p. S112-
1 p.
 artikel
542 226. Transient occupancy at the D2 receptor—a new hypothesis for atypical antipsychotics Kapur, S.
 2000
 47 8S1 p. S69-
1 p.
 artikel
543 547. Traumatic events and borderline personality disorder Mitropoulou, V.
 2000
 47 8S1 p. S166-S167
2 p.
 artikel
544 302. Treating dysthymia in primary care: sertraline vs IPT (a two-year follow up) Steiner, M.
 2000
 47 8S1 p. S91-
1 p.
 artikel
545 297. Treatment of bipolar disorder with adjunctive risperidone Vieta, E.
 2000
 47 8S1 p. S90-
1 p.
 artikel
546 266. Treatment with the presynaptic 5-HT1A-antagonist pindolol in patients with panic disorder Ziegenbein, M.
 2000
 47 8S1 p. S81-
1 p.
 artikel
547 299. Urogenital and sexual effects of reboxetine: four single cases Hilger, E.
 2000
 47 8S1 p. S90-S91
2 p.
 artikel
548 128. Use of objective measures of motor function to differentiate olanzapine and risperidone Rapaport, M.H.
 2000
 47 8S1 p. S39-
1 p.
 artikel
549 561. Using twin data to define drug abuse phenotypes Tsuang, M.T.
 2000
 47 8S1 p. S171-
1 p.
 artikel
550 149. Verbal and physical aggression in poor outcome, geriatric schizophrenia Bowie, C.R.
 2000
 47 8S1 p. S45-
1 p.
 artikel
551 396. Verbal memory and hippocampal volumes in relatives of patients with schizophrenia Tsuang, M.T.
 2000
 47 8S1 p. S121-
1 p.
 artikel
552 56. Viral infections and cytokine levels in “nonorganic” psychoses Gangadhar, B.N.
 2000
 47 8S1 p. S17-
1 p.
 artikel
553 110. Visual contrast detection to evaluate the dopamine system in schizophrenia Chen, Y.
 2000
 47 8S1 p. S33-
1 p.
 artikel
554 143. Visual memory deficits in schizophrenia Fleming-Ficek, S.K.
 2000
 47 8S1 p. S43-
1 p.
 artikel
555 225. Volumetric magnetic resonance imaging in twins concordant and discordant for schizophrenia Sharma, T.
 2000
 47 8S1 p. S68-S69
2 p.
 artikel
556 168. Volumetric MRI in male violent offenders with schizophrenia and psychopathic disorder Sharma, T.
 2000
 47 8S1 p. S51-
1 p.
 artikel
557 117. Vulnerability markers in schizotypal personality disorder: defining a phenotype Cadenhead, K.S.
 2000
 47 8S1 p. S35-S36
2 p.
 artikel
558 159. Weight gain and response to olanzapine treatment in schizophrenia Ritter, L.M.
 2000
 47 8S1 p. S48-
1 p.
 artikel
559 131. What could be accounting for olfactory identification (UPSIT) errors in schizophrenia? Minor, K.
 2000
 47 8S1 p. S39-S40
2 p.
 artikel
560 501. White gray matter ratios in the parahippocampal gyrus of paraphrenia Casanova, M.F.
 2000
 47 8S1 p. S152-
1 p.
 artikel
561 537. White matter fractional anisotropy and lorazepam-induced cognitive toxicity in the elderly Pomara, N.
 2000
 47 8S1 p. S163-S164
2 p.
 artikel
562 274. withdrawn 2000
 47 8S1 p. S83-
1 p.
 artikel
563 246. withdrawn 2000
 47 8S1 p. S75-
1 p.
 artikel
564 525. withdrawn 2000
 47 8S1 p. S160-
1 p.
 artikel
565 203. Working memory: constructs, neural circuits, and pharmacological modulation Belger, A.
 2000
 47 8S1 p. S62-
1 p.
 artikel
566 126. Working memory impairment in schizophrenia patients and their first-degree relatives Conklin, H.M.
 2000
 47 8S1 p. S38-
1 p.
 artikel
567 50. Ziprasidone blocks ketamine-induced brain metabolic activation Duncan, G.E.
 2000
 47 8S1 p. S15-
1 p.
 artikel
                             567 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland